Kruse-Jarres R - Search Results

1

Unexpected pharmacokinetics of recombinant porcine factor VIII in a patient with acquired factor VIII deficiency and spontaneous epidural haematoma.

Shatzel JJ, Azar S, Scherber R, Gay N, Deloughery TG, VanSandt A, Kruse-Jarres R, Recht M, Taylor JA. Shatzel JJ, et al. Haemophilia. 2017 Sep;23(5):e453-e456. doi: 10.1111/hae.13247. Epub 2017 Jun 29. Haemophilia. 2017. PMID: 28664642 No abstract available.

2

How I treat von Willebrand disorders in older adults.

Poston JN, Kruse-Jarres R. Poston JN, et al. Among authors: kruse jarres r. Blood. 2024 Jan 18;143(3):197-204. doi: 10.1182/blood.2022018534. Blood. 2024. PMID: 37672774

3

Inhibitors: our greatest challenge. Can we minimize the incidence?

Kruse-Jarres R. Kruse-Jarres R. Haemophilia. 2013 Jan;19 Suppl 1:2-7. doi: 10.1111/hae.12049. Haemophilia. 2013. PMID: 23278993 Review.

4

Haemophilia A and inhibitors: advances in prevention and ITI treatment optimization.

Kruse-Jarres R. Kruse-Jarres R. Haemophilia. 2014 Sep;20 Suppl 6:1. doi: 10.1111/hae.12464. Haemophilia. 2014. PMID: 24975699 No abstract available.

5

Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.

Kruse-Jarres R, St-Louis J, Greist A, Shapiro A, Smith H, Chowdary P, Drebes A, Gomperts E, Bourgeois C, Mo M, Novack A, Farin H, Ewenstein B. Kruse-Jarres R, et al. Haemophilia. 2015 Mar;21(2):162-170. doi: 10.1111/hae.12627. Epub 2015 Jan 27. Haemophilia. 2015. PMID: 25623166 Clinical Trial.

6

Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry.

Kruse-Jarres R, Gilsenan A, Spears J, Kaye JA. Kruse-Jarres R, et al. Haemophilia. 2015 Mar;21(2):e122-e124. doi: 10.1111/hae.12590. Epub 2015 Jan 27. Haemophilia. 2015. PMID: 25623889 No abstract available.

7

US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors.

Valentino LA, Kempton CL, Kruse-Jarres R, Mathew P, Meeks SL, Reiss UM; International Immune Tolerance Induction Study Investigators. Valentino LA, et al. Haemophilia. 2015 Sep;21(5):559-67. doi: 10.1111/hae.12730. Epub 2015 Jun 2. Haemophilia. 2015. PMID: 26032231 Review.

8

A new era for hemophilia B treatment.

Taylor JA, Kruse-Jarres R. Taylor JA, et al. Blood. 2016 Apr 7;127(14):1734-6. doi: 10.1182/blood-2016-02-694869. Blood. 2016. PMID: 27056991 Free PMC article.

9

Alternative therapies for the management of inhibitors.

Shima M, Lillicrap D, Kruse-Jarres R. Shima M, et al. Haemophilia. 2016 Jul;22 Suppl 5:36-41. doi: 10.1111/hae.13005. Haemophilia. 2016. PMID: 27405674

10

Emicizumab for hemophilia A with factor VIII inhibitors.

Young G, Callaghan M, Dunn A, Kruse-Jarres R, Pipe S. Young G, et al. Expert Rev Hematol. 2018 Nov;11(11):835-846. doi: 10.1080/17474086.2018.1531701. Epub 2018 Oct 10. Expert Rev Hematol. 2018. PMID: 30278802 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters